STRIDES PHARMA SCIENCE LIMITED — Capital/Financing Update 2018

Dec 11, 2018

December 11, 2018

BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001

Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza , Bandra‐Kurla Complex Bandra (E) Mumbai ‐ 400 051

Scrip code: STAR

Dear Sirs,

Sub: Press Release

Please find attached press release issued by the Company titled:

“Strides Vivimed JV receives approval for Albendazole Tablets”

Thanks and Regards

For Strides Pharma Science Limited

==> picture [150 x 58] intentionally omitted <==

Manjula Ramamurthy Company Secretary

==> picture [96 x 86] intentionally omitted <==

Strides Pharma Science Limited

(Formerly Strides Shasun Limited) CIN: L24230MH1990PLC057062 Corp Off : Strides House, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India Tel: +91 80 6784 0000 Fax: +91 80 6784 0700 Regd Off : 201, Devavrata, Sector 17, Vashi, Navi Mumbai – 400 703, India Tel: +91 22 2789 2924 / 3199 Fax: +91 22 2789 2942 info@strides.com; www.strides.com

Press Release December 11, 2018

Strides Vivimed JV receives approval for Albendazole Tablets

Second generic approval by US FDA for Albendazole Tablets Product to be launched immediately

Bangalore, December 11, 2018 Strides Pharma Science Limited (Strides) today announced that its 50:50 JV Strides Vivimed Pte. Ltd, Singapore has received approval for Albendazole Tablets USP 200 mg from the United States Food & Drug Administration (US FDA). This is the second generic approval by US FDA for Albendazole Tablets.

Albendazole Tablets is a generic version of Albenza Tablets® of Amneal Pharmaceuticals, Inc. According to IQVIA MAT data, the US market for Albendazole Tablets USP 200 mg is approximately US$ 100 Mn.

About Albendazole Tablets

Albendazole is an anthelmintic medication used to treat certain infections caused by tapeworm. Albendazole prevents newly hatched insect larvae (worms) from growing or multiplying in the body.

About Strides

Strides, listed on the BSE Limited (532531) and National Stock Exchange of India Limited (STAR), is global pharmaceutical Company headquartered in Bangalore. The Company has two business verticals, viz., Regulated Markets and Emerging Markets. The Company has a global manufacturing footprint with 7 manufacturing facilities spread across three continents including 5 facilities for Regulated Markets and 2 facilities for the Emerging Markets. The Company has strong R&D infrastructure in India with global filing capabilities and a strong commercial footprint across 100 countries. Additional information is available at the Company’s website at www.strides.com

For further information, please contact:

StridesBadree KomandurExecutive Director ‐ Finance+91 80 6784 0747Investor Relations:Kannan. N: +91 98450 54745Vikesh Kumar: +91 80 6784 0827Sandeep Baid : +91 80 6784 0791Email: Sandeep.baid@strides.com	s	PR ConsultancyFortuna PRK Srinivas Reddy: +91 90005 27213rinivas@fortunapr.comK Priya: +91 95354 25418priya@fortunapr.com

Strides Pharma Science Limited (Formerly Strides Shasun Limited) CIN : L24230MH1990PLC057062 Regd. Office: 201, ‘Devavrata’, Sector ‐ 17, Vashi, Navi Mumbai ‐ 400 703 Corp. Office: Strides House, Bannerghatta Road, Bangalore – 560076